Users receiving weekly injections saw their weight fall, plateau, and stabilize over the course of a four-year trial—but it’s ...
The drug, Wegovy, uses an active ingredient called Semaglutide which is part of a growing class of GLP-1 drugs that make ...
A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four ...
A study in Nature Medicine evaluated the effects of semaglutide on weight and anthropometric outcomes in adults with obesity but without diabetes, finding significant weight loss and improved health ...
Altimmune is developing Pemvidutide, a drug that shows promising results in fat and weight loss. See why Pemvidutide's ...
The benefit-harm balance of initiating Glucagon-like Peptide-1 (GLP-1) receptor agonists (RAs) versus a placebo intervention.
The number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic for weight loss and ...
The study found that the majority of people on Wegovy lost weight, on average 10% of their body weight, in the first 15 months of using the medication and sustained their weight loss over four years ...
Got questions about weight loss drugs? We’re covering all the basics of these newer pharmaceuticals, from who needs them to ...
From how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...